Fulltext

Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study

Kurth, Florian

In: Clinical Infectious Diseases, 2015, vol. 61, no. 9, p. 1441-1444

Ajouter à la liste personnelle
    Titre
    • Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study
    Auteur
    • Kurth, Florian
    Contributeur
    • Develoux, Michel. joint author
    • Mechain, Matthieu. joint author
    • Clerinx, Jan. joint author
    • et al. joint author
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Clinical Infectious Diseases, 2015, vol. 61, no. 9, p. 1441-1444. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:299894
    Summary
    Intravenous artesunate improves survival in severe malaria, but clinical trial data from nonendemic countries are scarce. The TropNet severe malaria database was analyzed to compare outcomes of artesunate vs quinine treatment. Artesunate reduced parasite clearance time and duration of intensive care unit and hospital treatment in European patients with imported severe malaria